Induction of muscle weakness by local inflammation: an experimental animal model S. BicerP. J. ReiserN. Quan OriginalPaper 11 February 2009 Pages: 175 - 183
Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells S.-J. LeeK.-T. Lim OriginalPaper 13 February 2009 Pages: 184 - 191
Concentrations of α- and β-defensins in plasma of patients with inflammatory bowel disease N. YamaguchiH. IsomotoS. Kohno OriginalPaper 31 January 2009 Pages: 192 - 197
Neutrophil elastase inhibitor (sivelestat) reduces the Levels of inflammatory mediators by inhibiting NF-kB S. HagiwaraH. IwasakaT. Noguchi OriginalPaper 24 February 2009 Pages: 198 - 203
A new model of outbred genetically selected mice which present a strong acute inflammatory response in the absence of complement component C5 M. T. AmanoA. S. CarneiroN. Starobinas OriginalPaper 24 January 2009 Pages: 204 - 209
Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme E. A. AragãoL. ChioatoR. J. Ward OriginalPaper 24 January 2009 Pages: 210 - 217
3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn’s disease in Tunisian population R. MarrakchiK. BougatefA. Benammar-Elgaaeid OriginalPaper 30 January 2009 Pages: 218 - 223
Enhancement of activated β1-integrin expression by prostaglandin E2 via EP receptors in isolated human coronary arterial endothelial cells: implication for the treatment of Kawasaki disease M. KajimotoT. IchiyamaS. Furukawa OriginalPaper 24 January 2009 Pages: 224 - 228